Works matching IS 0741238X AND DT 2022 AND VI 39 AND IP 5


Results: 27
    1
    2
    3
    4
    5
    6
    7

    The Economic Burden of Insulin Injection-Induced Lipohypertophy. Role of Education: The ISTERP-3 Study.

    Published in:
    Advances in Therapy, 2022, v. 39, n. 5, p. 2192, doi. 10.1007/s12325-022-02105-5
    By:
    • Gentile, Sandro;
    • Guarino, Giuseppina;
    • Della Corte, Teresa;
    • Marino, Giampiero;
    • Satta, Ersilia;
    • Pasquarella, Maria;
    • Romano, Carmine;
    • Alfrone, Carmelo;
    • Giordano, Laura;
    • Loiacono, Fabrizio;
    • Capece, Maurizio;
    • Lamberti, Rossella;
    • Strollo, Felice;
    • Nefrocenter and Nyx Start-up, AMDOSDI Study Group on Injection Techniques, and ANIAD;
    • De-Riu, Stefano;
    • De-Rosa, Nicoletta;
    • Grassi, Giorgio;
    • Garrapa, Gabriella;
    • Tonutti, Laura;
    • Speese, Katija
    Publication type:
    Article
    8
    9

    Impact of Infliximab-dyyb (Infliximab Biosimilar) on Clinical and Patient-Reported Outcomes: 1-Year Follow-up Results from an Observational Real-World Study Among Patients with Inflammatory Bowel Disease in the US and Canada (the ONWARD Study).

    Published in:
    Advances in Therapy, 2022, v. 39, n. 5, p. 2109, doi. 10.1007/s12325-022-02104-6
    By:
    • Abraham, Bincy;
    • Eksteen, Bertus;
    • Nedd, Khan;
    • Kale, Hrishikesh;
    • Patel, Dipen;
    • Stephens, Jennifer;
    • Shelbaya, Ahmed;
    • Chambers, Richard;
    • Soonasra, Arif
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27